Giving a Voice to Patients With Smell Disorders Associated With COVID-19: Cross-Sectional Longitudinal Analysis Using Natural Language Processing of Self-Reports.

Journal: JMIR public health and surveillance
PMID:

Abstract

BACKGROUND: Smell disorders are commonly reported with COVID-19 infection. The smell-related issues associated with COVID-19 may be prolonged, even after the respiratory symptoms are resolved. These smell dysfunctions can range from anosmia (complete loss of smell) or hyposmia (reduced sense of smell) to parosmia (smells perceived differently) or phantosmia (smells perceived without an odor source being present). Similar to the difficulty that people experience when talking about their smell experiences, patients find it difficult to express or label the symptoms they experience, thereby complicating diagnosis. The complexity of these symptoms can be an additional burden for patients and health care providers and thus needs further investigation.

Authors

  • Nick S Menger
    Institute of Medical Psychology and Behavioural Neurobiology, University of Tübingen, Tübingen, Germany.
  • Arnaud Tognetti
    Department of Clinical Neuroscience, Division of Psychology, Karolinska Institutet, Stockholm, Sweden.
  • Michael C Farruggia
    Interdepartmental Neuroscience Program, Yale University, New Haven, Connecticut.
  • Carla Mucignat
    Department of Molecular Medicine, University of Padova, Padua, Italy.
  • Surabhi Bhutani
    School of Exercise and Nutritional Sciences, San Diego State University, San Diego, CA, United States.
  • Keiland W Cooper
    Department of Neurobiology and Behavior, University of California, Irvine, CA, United States.
  • Paloma Rohlfs Domínguez
    Department of Developmental and Educational Psychology, University of Basque Country, Leioa, Spain.
  • Thomas Heinbockel
    Department of Anatomy, Howard University College of Medicine, Washington, DC, United States.
  • Vonnie D C Shields
    Biological Sciences Department, Fisher College of Science and Mathematics, Towson University, Towson, MD, United States.
  • Anna D'Errico
    Goethe University of Frankfurt, Frankfurt am Main, Germany.
  • Veronica Pereda-Loth
    Laboratoire Évolution et Santé Orale, Université Toulouse III, Toulouse, France.
  • Denis Pierron
    Laboratoire Évolution et Santé Orale, Université Toulouse III, Toulouse, France.
  • Sachiko Koyama
    Department of Medicine, School of Medicine, Indiana University, Indianapolis, IN, United States.
  • Ilja Croijmans
    Language and Communication Department, Faculty of Arts, Radboud University, Nijmegen, Netherlands.